On December 19, 2023, ST Jiyao issued the "Announcement on the Public Recruitment of Reorganization Investors of Jiyao Holding Group Co., Ltd.", and the Intermediate People's Court of Tonghua City, Jilin Province decided to start the pre-reorganization procedure for the shares of Jiyao Holding Group, and appointed the bankruptcy reorganization liquidation group of Jiyao Holding Group as the interim administrator of Jiyao Holdings. In order to promote the pre-reorganization and reorganization of Jiyao Holdings, the interim manager decided to publicly recruit reorganization investors. The recruitment conditions include that the investor should be a validly existing corporate legal person or unincorporated organization, with sufficient financial strength and a clear decision-making process. The deadline for entries is January 8, 2024. The purpose of recruiting reorganization investors is to achieve the successful reorganization of Jiyao Holdings, introduce capital, management and industrial support, optimize the asset structure, debt structure and equity structure, resolve the debt crisis and restore profitability. The company intends to introduce no more than 10 reorganization investors, and each reorganization investor intends to subscribe for shares not less than 05%。
Jiyao Holding Group Co., Ltd. was listed on the Growth Enterprise Market of the Shenzhen Stock Exchange on August 25, 2010, and its main business is to take the pharmaceutical and health industry as the core, pharmaceutical industry, pharmaceutical business (including drug retail), pharmaceutical research and development, medical care, pharmaceutical industry investment, etc. In the national economic industry, it belongs to the manufacturing industry and the pharmaceutical manufacturing industryIn terms of Shenwan industry classification, it belongs to the major category of medicine and biology and the small category of traditional Chinese medicine. As of October 25, 2023, the actual controllers of the company are Huang Kefeng and Lu Zhongkui. According to the data, the company has been treated by ST on or around October 25, 2023 and June 30, 2022.
As of December 19, 2023**, the company's share price is 315 yuan shares, with a circulating market value of 206.8 billion yuan.
Announcement**: Disclaimer: This article is written by the robot, jointly incubated by Pencil Road and Hanxin Society, and the main data is provided by Hanguang Suwen. The content and data in this article are for reference only and do not constitute investment advice.